Announcements Trials
Browse Landscape

Phase

Phase 1 31Phase 2 6Phase 4 4Phase 3 3Phase NA 2Phase 2/3 1

Status

Not yet recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1Breast 1

Conditions

Venous Thromboembolism 1Stroke 1Pulmonary Embolism 1Prostatic Neoplasms 1Neoplasms 1Ischemic Attack, Transient 1Hypoalphalipoproteinemias 1Cardiovascular Diseases 1Cardiotoxicity 1Breast Neoplasms 1Atherosclerosis 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Rosuvastatin Calcium × Clear all
NCT07303816 2026-05-18

STAT-CAT

Brigham and Women's Hospital

Phase 4 Not yet recruiting
4,000 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting
400 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT04776889 2021-03-02

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

National Cancer Institute, Egypt

Phase 4 Completed
70 enrolled
Genitourinary

Prostatic Neoplasms, Hypoalphalipoproteinemias

NCT02114697 2018-09-11

Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging

Emory University

Phase 4 Terminated
9 enrolled 6 charts

Cardiovascular Diseases, Ischemic Attack, Transient, Stroke, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡